Did you know? Canada has one of the highest incidence rates of #InflammatoryBowelDisease (IBD) in the world, and those numbers are expected to rise over the coming decade, according to Crohn's and Colitis Canada | Crohn et Colite Canada. On World IBD Day, explore how UBC researchers are working to improve the lives of people with #IBD through an innovative new drug delivery method that directly targets the gut. ➡️ bit.ly/43Clqu0
What if your gut bacteria could activate your medication—only where it’s needed? ➡️ bit.ly/4k2y6zW UBC researchers have developed a new drug delivery method, called "GlycoCaging", that targets the release of medication directly to the lower gut. The result could mean: lower doses, fewer side effects and a path toward more precise treatment of conditions like #IBD and more. Explore how this breakthrough, published today in Science Magazine, could revolutionize treatment.